AU765876C - Methods for selectively stimulating proliferation of T cells - Google Patents

Methods for selectively stimulating proliferation of T cells

Info

Publication number
AU765876C
AU765876C AU26464/01A AU2646401A AU765876C AU 765876 C AU765876 C AU 765876C AU 26464/01 A AU26464/01 A AU 26464/01A AU 2646401 A AU2646401 A AU 2646401A AU 765876 C AU765876 C AU 765876C
Authority
AU
Australia
Prior art keywords
cells
methods
stimulating proliferation
selectively stimulating
selectively
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU26464/01A
Other versions
AU2646401A (en
AU765876B2 (en
Inventor
Gary S. Gray
Carl H June
Gary J Nabel
Paul D Rennert
Craig B Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Repligen Corp
University of Michigan
US Department of Navy
Original Assignee
Repligen Corp
University of Michigan
US Department of Navy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU89487/98A external-priority patent/AU727438C/en
Application filed by Repligen Corp, University of Michigan, US Department of Navy filed Critical Repligen Corp
Priority to AU26464/01A priority Critical patent/AU765876C/en
Publication of AU2646401A publication Critical patent/AU2646401A/en
Application granted granted Critical
Publication of AU765876B2 publication Critical patent/AU765876B2/en
Priority to AU2003257530A priority patent/AU2003257530B8/en
Priority to AU2003257877A priority patent/AU2003257877B2/en
Publication of AU765876C publication Critical patent/AU765876C/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU26464/01A 1993-06-04 2001-03-12 Methods for selectively stimulating proliferation of T cells Expired AU765876C (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU26464/01A AU765876C (en) 1993-06-04 2001-03-12 Methods for selectively stimulating proliferation of T cells
AU2003257530A AU2003257530B8 (en) 1993-06-04 2003-10-23 Methods for selectively stimulating proliferation of T cells (D1)
AU2003257877A AU2003257877B2 (en) 1993-06-04 2003-10-24 Methods for selectively stimulating proliferation of T cells (D2)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US073223 1993-06-04
AU89487/98A AU727438C (en) 1993-06-04 1998-10-22 Methods for selectively stimulating proliferation of T cells
AU26464/01A AU765876C (en) 1993-06-04 2001-03-12 Methods for selectively stimulating proliferation of T cells

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU89487/98A Division AU727438C (en) 1993-06-04 1998-10-22 Methods for selectively stimulating proliferation of T cells

Related Child Applications (2)

Application Number Title Priority Date Filing Date
AU2003257530A Division AU2003257530B8 (en) 1993-06-04 2003-10-23 Methods for selectively stimulating proliferation of T cells (D1)
AU2003257877A Division AU2003257877B2 (en) 1993-06-04 2003-10-24 Methods for selectively stimulating proliferation of T cells (D2)

Publications (3)

Publication Number Publication Date
AU2646401A AU2646401A (en) 2001-05-17
AU765876B2 AU765876B2 (en) 2003-10-02
AU765876C true AU765876C (en) 2004-05-20

Family

ID=28795563

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26464/01A Expired AU765876C (en) 1993-06-04 2001-03-12 Methods for selectively stimulating proliferation of T cells

Country Status (1)

Country Link
AU (1) AU765876C (en)

Also Published As

Publication number Publication date
AU2646401A (en) 2001-05-17
AU765876B2 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
AU5268696A (en) Novel compounds and methods for therapy
IL109008A0 (en) Immunoassy for determination of cells
AU4655296A (en) Compositions and methods for treating tumor cells
AU4754393A (en) Cell culture insert
AU4754493A (en) Cell culture insert
AU5975694A (en) Electrotherapeutic apparatus
AU5533094A (en) Enzyme inhibitors
AU1039995A (en) System and assemblage for producing microtexturized substrates and implants
AU4139196A (en) Method and composition for antiviral therapy
AU5218593A (en) Method of milling
AU1089995A (en) Control of cell growth
AU3769097A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
AU4296397A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
AU6167394A (en) Selective cell proliferation
AU4410893A (en) Electrolytic cell
AU4639596A (en) Inhibition of glial cell proliferation
AU5116596A (en) Cell culture method
AU2844889A (en) Method for suppressing the growth of normal and cancer cells
EP0599514A3 (en) Pyranoquinoline derivatives as inhibitors of cell proliferation.
AU621181B2 (en) Immune cell proliferation inhibitors
AU3730093A (en) Methods of treating diabetes
AU4584893A (en) Magnetotherapy apparatus
AU6130196A (en) Cell treatment
AU4677496A (en) Use of helioxanthin as an enhancer of cell differentiation inducing factors
AUPO235996A0 (en) Method of cell culture

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20031003

FGA Letters patent sealed or granted (standard patent)
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 20031106